ORGANIZATION

• Generic Use Rate at 80.7% in FY2022: JGA
  June 30, 2023

• Citizens’ Group Opposes Pilot Switch Program for Emergency Contraceptives
  June 27, 2023

• FPMAJ Chief Shows Enthusiasm toward Drug Pricing Reform, Vows to Exchange Views with All Affiliate Groups
  June 26, 2023

• New JPMA Director General Keen to Make “Special Price Maintenance” Happen after 15 Years
  June 23, 2023

• FPMAJ Makes 1st Update for Generic Supply Guidelines in 9 Years
  June 22, 2023

• Patient Group Requests Early Approval of New ALS Drugs in Japan
  June 22, 2023

• Astellas’ Yoshitsugu Shitaka Elected as New FIRM Chair
  June 20, 2023

• Lag and Loss Blamed on Drug Pricing System, JPMA Set to Get Involved in Corrective Steps: President
  June 15, 2023

• Over 70% of Pharmacies Fill “Zero” Refill Prescriptions per Month: FPMAJ Survey
  June 13, 2023

• FPMAJ Demands Better Criteria for Selecting Comparator Drugs to Factor in Disease Features and Product Positioning
  June 12, 2023

• PMP Company Criteria Mar Market Attractiveness, Scrap Them: FPMAJ
  June 12, 2023

• Tide Has Changed, but That Doesn’t Erase Concerns: FPMAJ Drug Pricing Chief
  June 12, 2023

• Regenerative Medicine Group Hails Expert Panel’s Proposal on New Pricing Method for Innovative Therapies
  June 9, 2023

• JMA Renews Opposition for Health Coverage Review for Pharmaceuticals
  June 8, 2023

• Pharma Hails Expert Panel Report, Looks for Govt Leadership to Execute Reforms
  June 7, 2023

• Industry’s Concerns Beginning to Sink in among Policymakers: JPMA Committee Chair
  June 7, 2023

• Protect Info for Off-Patent Brands Even after Market Exit: JEMA
  May 29, 2023

• Eisai’s Yasushi Okada Becomes FPMAJ Chairman
  May 26, 2023

• New JPMA Chief Renews Resolve for Drug Price Maintenance, Dynamic Policies
  May 26, 2023

• 12 Medical and Nursing Care Groups Demand Responses to Inflation, Wage Hikes
  May 26, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• …
• Next ›
• 最終 »